![Proactive Monitoring of Adalimumab Trough Concentration Associated With Increased Clinical Remission in Children With Crohn's Disease Compared With Reactive Monitoring - ScienceDirect Proactive Monitoring of Adalimumab Trough Concentration Associated With Increased Clinical Remission in Children With Crohn's Disease Compared With Reactive Monitoring - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0016508519410007-fx1.jpg)
Proactive Monitoring of Adalimumab Trough Concentration Associated With Increased Clinical Remission in Children With Crohn's Disease Compared With Reactive Monitoring - ScienceDirect
![Evaluation of anti-TNF therapeutic response in patients with inflammatory bowel disease: Current and novel biomarkers - eBioMedicine Evaluation of anti-TNF therapeutic response in patients with inflammatory bowel disease: Current and novel biomarkers - eBioMedicine](https://www.thelancet.com/cms/attachment/c74b52d1-ea65-44cf-a936-74af326c8eaf/gr1_lrg.jpg)
Evaluation of anti-TNF therapeutic response in patients with inflammatory bowel disease: Current and novel biomarkers - eBioMedicine
![Dynamics of circulating TNF during adalimumab treatment using a drug-tolerant TNF assay | Science Translational Medicine Dynamics of circulating TNF during adalimumab treatment using a drug-tolerant TNF assay | Science Translational Medicine](https://www.science.org/cms/10.1126/scitranslmed.aat3356/asset/0404e282-2d5e-4318-b333-29d3d1fc07f0/assets/graphic/aat3356-f1.jpeg)
Dynamics of circulating TNF during adalimumab treatment using a drug-tolerant TNF assay | Science Translational Medicine
Immunopharmacologic Monitoring of Therapeutic Serum Antibodies I. Policy Description II. Related Policies III. Indications and/o
Dried blood spots from finger prick facilitate therapeutic drug monitoring of adalimumab and antiв•'adalimumab in patients
![Frontiers | The First WHO International Standard for Adalimumab: Dual Role in Bioactivity and Therapeutic Drug Monitoring Frontiers | The First WHO International Standard for Adalimumab: Dual Role in Bioactivity and Therapeutic Drug Monitoring](https://www.frontiersin.org/files/Articles/636420/fimmu-12-636420-HTML-r1/image_m/fimmu-12-636420-t001.jpg)
Frontiers | The First WHO International Standard for Adalimumab: Dual Role in Bioactivity and Therapeutic Drug Monitoring
![Tailoring anti-TNF therapy in IBD: drug levels and disease activity | Nature Reviews Gastroenterology & Hepatology Tailoring anti-TNF therapy in IBD: drug levels and disease activity | Nature Reviews Gastroenterology & Hepatology](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fnrgastro.2013.253/MediaObjects/41575_2014_Article_BFnrgastro2013253_Fig1_HTML.jpg)
Tailoring anti-TNF therapy in IBD: drug levels and disease activity | Nature Reviews Gastroenterology & Hepatology
Therapeutic monitoring of adalimumab at non-trough levels in patients with inflammatory bowel disease | PLOS ONE
![Striking a new path – extending the diagnostic portfolio by test systems for therapeutic drug monitoring - EUROIMMUNBlog Striking a new path – extending the diagnostic portfolio by test systems for therapeutic drug monitoring - EUROIMMUNBlog](https://www.euroimmunblog.de/wp-content/uploads/2020/11/Effects-of-MAb.jpg)
Striking a new path – extending the diagnostic portfolio by test systems for therapeutic drug monitoring - EUROIMMUNBlog
Clinical Specialist Services Care Group Department of Pathology - Immunology ADALIMUMAB MONITORING Includes: Serum adalimumab, a
Therapeutic monitoring of adalimumab at non-trough levels in patients with inflammatory bowel disease | PLOS ONE
![POS0621 DISEASE-SPECIFIC ADVERSE DRUG REACTION PROFILES OF ADALIMUMAB AND ETANERCEPT AS REPORTED BY IMMUNE-MEDIATED INFLAMMATORY DISEASE PATIENTS | Annals of the Rheumatic Diseases POS0621 DISEASE-SPECIFIC ADVERSE DRUG REACTION PROFILES OF ADALIMUMAB AND ETANERCEPT AS REPORTED BY IMMUNE-MEDIATED INFLAMMATORY DISEASE PATIENTS | Annals of the Rheumatic Diseases](https://ard.bmj.com/content/annrheumdis/80/Suppl_1/548/F1.large.jpg)
POS0621 DISEASE-SPECIFIC ADVERSE DRUG REACTION PROFILES OF ADALIMUMAB AND ETANERCEPT AS REPORTED BY IMMUNE-MEDIATED INFLAMMATORY DISEASE PATIENTS | Annals of the Rheumatic Diseases
![Frontiers | Clinical Evaluation of Humira® Biosimilar ONS-3010 in Healthy Volunteers: Focus on Pharmacokinetics and Pharmacodynamics Frontiers | Clinical Evaluation of Humira® Biosimilar ONS-3010 in Healthy Volunteers: Focus on Pharmacokinetics and Pharmacodynamics](https://www.frontiersin.org/files/MyHome%20Article%20Library/221738/221738_Thumb_400.jpg)
Frontiers | Clinical Evaluation of Humira® Biosimilar ONS-3010 in Healthy Volunteers: Focus on Pharmacokinetics and Pharmacodynamics
![Optimizing Therapies Using Therapeutic Drug Monitoring: Current Strategies and Future Perspectives - Gastroenterology Optimizing Therapies Using Therapeutic Drug Monitoring: Current Strategies and Future Perspectives - Gastroenterology](https://www.gastrojournal.org/cms/asset/2b26323d-30d0-4a74-a734-19065e6c9cb0/gr1.jpg)
Optimizing Therapies Using Therapeutic Drug Monitoring: Current Strategies and Future Perspectives - Gastroenterology
![Monitoring of adalimumab and antibodies-to-adalimumab levels in patient serum by the homogeneous mobility shift assay - ScienceDirect Monitoring of adalimumab and antibodies-to-adalimumab levels in patient serum by the homogeneous mobility shift assay - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0731708513000484-fx1.jpg)